HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: BSE

This article was originally published in The Rose Sheet

Executive Summary

BSE: FDA's Transmissible Spongiform Encephalopathies Advisory Committee to meet April 23 from 8 a.m. to 6 p.m., and April 24 from 8 a.m. to 5 p.m. to discuss and provide recommendations on the potential risk of gelatin and gelatin by-products with regard to the transmission of bovine spongiform encephalopathy. The meeting will be held at the Holiday Inn in Bethesda, Md. in Versailles Ballrooms III and IV. The public portion of the meeting will be held from 9 a.m. to 10 a.m. April 23 with open committee discussion to follow the rest of that day and on April 24...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS003992

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel